AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer

Clinical trial NCT07021950 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07021950
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Ivonescimab

Start date: 2025-08-10
Primary completion: 2027-10-31
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.